Filing Flows › TG Therapeutics (TGTX) › License, milestone, royalty and other revenue revenue
TG Therapeutics (TGTX) License, milestone, royalty and other revenue revenue by quarter
TG Therapeutics' License, milestone, royalty and other revenue revenue was $19.9M in Q3 2026 (third quarter 2026), +338% from Q2 2026. Over the last 6 quarters it ranged from $2.3M (Q2 2025) to $19.9M (Q3 2026).
| Quarter | License, milestone, royalty and other revenue revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $19.9M | +338% | +732% |
| Q2 2026 | $4.5M | +26% | +97% |
| Q1 2026 | $3.6M | +4% | — |
| Q4 2025 | $3.5M | +45% | — |
| Q3 2025 | $2.4M | +4% | — |
| Q2 2025 | $2.3M | — | — |
Q3 2026 at a glance
TG Therapeutics, Q3 2026: revenue $260M (+61% year over year), operating margin 33.0%, net earnings $55.5M, operating cash flow $45.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is TG Therapeutics' License, milestone, royalty and other revenue revenue?
TG Therapeutics' License, milestone, royalty and other revenue revenue was $19.9M in Q3 2026 (third quarter 2026), +338% from Q2 2026.
How has TG Therapeutics' License, milestone, royalty and other revenue revenue changed?
Over the last 6 quarters it ranged from $2.3M (Q2 2025) to $19.9M (Q3 2026).